Abstract

The galectin family of secreted lectins have emerged as important regulators of immune cell function; however, their role in B-cell responses is poorly understood. Here we identify IgM-BCR as a ligand for galectin-9. Furthermore, we show enhanced BCR microcluster formation and signaling in galectin-9-deficient B cells. Notably, treatment with exogenous recombinant galectin-9 nearly completely abolishes BCR signaling. We investigated the molecular mechanism for galectin-9-mediated inhibition of BCR signaling using super-resolution imaging and single-particle tracking. We show that galectin-9 merges pre-existing nanoclusters of IgM-BCR, immobilizes IgM-BCR, and relocalizes IgM-BCR together with the inhibitory molecules CD45 and CD22. In resting naive cells, we use dual-color super-resolution imaging to demonstrate that galectin-9 mediates the close association of IgM and CD22, and propose that the loss of this association provides a mechanism for enhanced activation of galectin-9-deficient B cells.

Details

Title
Galectin-9 binds IgM-BCR to regulate B cell signaling
Author
Cao, Anh 1   VIAFID ORCID Logo  ; Alluqmani, Nouf 2 ; Fatima Hifza Mohammed Buhari 3 ; Laabiah Wasim 1 ; Smith, Logan K 1 ; Quaile, Andrew T 4   VIAFID ORCID Logo  ; Shannon, Michael 5 ; Zaki Hakim 2 ; Hossai Furmli 3 ; Owen, Dylan M 5 ; Savchenko, Alexei 6 ; Treanor, Bebhinn 7   VIAFID ORCID Logo 

 Department of Immunology, University of Toronto, Toronto, ON, Canada 
 Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada 
 Department of Biological Sciences, University of Toronto Scarborough, Toronto, ON, Canada 
 Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada 
 Department of Physics and Randall Division of Cell and Molecular Biophysics, New Hunt’s House, King’s College London Guy’s Campus, London, UK 
 Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, Health Research Innovation Centre 4AA06, University of Calgary, Calgary, AB, Canada 
 Department of Immunology, University of Toronto, Toronto, ON, Canada; Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada; Department of Biological Sciences, University of Toronto Scarborough, Toronto, ON, Canada 
Pages
1-18
Publication year
2018
Publication date
Aug 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2090573966
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.